BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33840694)

  • 1. Immune Reconstitution Inflammatory Syndrome-like Condition Associated with Pneumocystis jirovecii Pneumonia During Folinic Acid Treatment in a Rheumatoid Arthritis Patient.
    Arakawa N; Eguchi K; Nakamura Y; Tsukahara Y; Koushima Y; Matsushima H
    Intern Med; 2021 Oct; 60(19):3143-3147. PubMed ID: 33840694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Reconstitution Inflammatory Syndrome Associated with Pneumocystis jirovecii Pneumonia and Cytomegalovirus Colitis in a Patient with Rheumatoid Arthritis.
    Shima N; Kokuzawa A; Saito K; Kamata Y; Nagashima T; Sato K
    Intern Med; 2022 Jan; 61(2):245-248. PubMed ID: 34248117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with Pneumocystis jirovecii pneumonia.
    Gochi M; Takayanagi N; Ishiguro T; Miyahara Y; Yanagisawa T; Shimizu Y; Sugita Y
    Intern Med; 2014; 53(11):1137-41. PubMed ID: 24881737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal perforation due to concomitant cytomegalovirus infection during treatment for Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis.
    Ishiguro T; Takayanagi N; Kawabata Y; Sugita Y
    Intern Med; 2011; 50(17):1835-7. PubMed ID: 21881284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
    Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
    BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodular granulomatous Pneumocystis jiroveci pneumonia consequent to delayed immune reconstitution inflammatory syndrome.
    Taeb AM; Sill JM; Derber CJ; Hooper MH
    Int J STD AIDS; 2018 Dec; 29(14):1451-1453. PubMed ID: 30114992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].
    Ikeuchi H; Umemoto A; Tsukida M; Sakurai N; Maeshima A; Kuroiwa T; Hiromura K; Nojima Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):420-5. PubMed ID: 22041430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases.
    Roux N; Flipo RM; Cortet B; Lafitte JJ; Tonnel AB; Duquesnoy B; Delcambre B
    Rev Rhum Engl Ed; 1996 Jun; 63(6):453-6. PubMed ID: 8817757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis jirovecii-associated immune reconstitution inflammatory syndrome-like phenomenon in a child with leukaemia: a case report and literature review.
    Lei JY; Chen H; Zhou DH; Xu LH; Fang JP; Mai YG
    BMC Pediatr; 2022 Jul; 22(1):410. PubMed ID: 35820900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia].
    Shimada T; Nishimura Y; Funada Y; Takenaka K; Kobayashi K; Urata Y; Yosimura S; Nishiuma T; Satouchi M; Yokoyama M
    Arerugi; 2004 Jun; 53(6):575-81. PubMed ID: 15247519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution inflammatory syndrome in a non-HIV immunocompromised patient with Pneumocystis Jirovecii pneumonia.
    Libardo RP; Razonable RR
    Transpl Infect Dis; 2022 Aug; 24(4):e13856. PubMed ID: 35598073
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
    Kato H; Samukawa S; Takahashi H; Nakajima H
    J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis jirovecii pneumonia developed in a patient with rheumatoid arthritis after 14 weeks of iguratimod add-on to treatment with methotrexate and etanercept.
    Arita Y; Taguchi H; Kobayashi M; Tono T; Ohsone Y; Okano Y
    Mod Rheumatol; 2018 Nov; 28(6):1041-1043. PubMed ID: 27180974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review].
    Bertisch B; Ruef C
    Z Rheumatol; 2006 Feb; 65(1):18-20, 22-3. PubMed ID: 16421640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
    Watanabe K; Sakai R; Koike R; Sakai F; Sugiyama H; Tanaka M; Komano Y; Akiyama Y; Mimura T; Kaneko M; Tokuda H; Iso T; Motegi M; Ikeda K; Nakajima H; Taki H; Kubota T; Kodama H; Sugii S; Kuroiwa T; Nawata Y; Shiozawa K; Ogata A; Sawada S; Matsukawa Y; Okazaki T; Mukai M; Iwahashi M; Saito K; Tanaka Y; Nanki T; Miyasaka N; Harigai M
    Mod Rheumatol; 2013 Nov; 23(6):1085-93. PubMed ID: 23212592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.
    Tokuda H; Sakai F; Yamada H; Johkoh T; Imamura A; Dohi M; Hirakata M; Yamada T; Kamatani N; Kikuchi Y; Sugii S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2008; 47(10):915-23. PubMed ID: 18480575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia.
    Lang B; Riegel W; Peters T; Peter HH
    J Rheumatol; 1991 Aug; 18(8):1257-9. PubMed ID: 1941837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
    Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
    Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Pneumocystis jirovecii Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study.
    Ohmura SI; Homma Y; Masui T; Miyamoto T
    Intern Med; 2022 Apr; 61(7):997-1006. PubMed ID: 34511571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.